- Report
- May 2024
- 185 Pages
Global
From €3977EUR$4,500USD£3,481GBP
- Report
- July 2025
- 200 Pages
Vietnam
From €2465EUR$2,789USD£2,158GBP
- Report
- June 2023
- 65 Pages
Global
From €3530EUR$3,995USD£3,091GBP
- Report
- January 2024
- 200 Pages
Global
From €3667EUR$4,150USD£3,211GBP
- Report
- June 2022
- 38 Pages
Global
From €3530EUR$3,995USD£3,091GBP
- Report
- March 2019
- 372 Pages
Global
€19441EUR$22,000USD£17,020GBP
- Book
- December 2018
- 277 Pages
From €114EUR$129USD£100GBP
The Arrhythmia market is a subset of the Cardiology market, focusing on the diagnosis and treatment of abnormal heart rhythms. Arrhythmias are caused by a variety of factors, including genetics, lifestyle, and underlying medical conditions. Treatment options include medications, lifestyle changes, and medical devices such as pacemakers and implantable cardioverter defibrillators (ICDs).
The Arrhythmia market is highly competitive, with a range of products and services available from a variety of companies. These include pharmaceutical companies, medical device manufacturers, and healthcare providers. Companies in the market include Abbott, Boston Scientific, Medtronic, St. Jude Medical, and Biotronik. Show Less Read more
